Carillo, Gabriel C.

HRN: 21-87-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/04/2022
09/10/2022
IV
2.25g
Q6H
T/C Sepsis; Covid Pneumonia Severe
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: